Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $5,060,568 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,970,000 | $699,851 | 13.8% | $133.73 | +52.0% | Common | 91307C102 |
| ARGX | ARGENX SE | 1,265,555 | $479,493 | 9.5% | $136.82 | — | Sponsored ADR | 04016X101 |
| APLS | APELLIS PHARMACEUTICALS INC | 9,805,000 | $443,382 | 8.8% | $47.70 | -4.4% | Common | 03753U106 |
| — | HORIZON THERAPEUTICS PLC | 5,000,000 | $398,800 | 7.9% | $48.54 | — | Common | G46188101 |
| — | MIRATI THERAPEUTICS INC | 5,550,555 | $372,609 | 7.4% | $53.82 | — | Common | 60468T105 |
| FOLD | AMICUS THERAPEUTICS INC | 26,800,000 | $287,832 | 5.7% | $10.43 | -21.1% | Common | 03152W109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,284,000 | $272,145 | 5.4% | $83.20 | -4.3% | Common | 09061G101 |
| — | SEAGEN INC | 1,525,000 | $269,834 | 5.3% | $148.58 | — | Common | 81181C104 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,390,000 | $254,114 | 5.0% | $97.25 | -24.3% | Common | 803607100 |
| ASND | ASCENDIS PHARMA | 2,275,000 | $211,484 | 4.2% | $130.04 | — | Sponsored ADR | 04351P101 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,360,000 | $198,356 | 3.9% | $153.75 | -7.7% | Common | 02043Q107 |
| XENE | XENON PHARMACEUTICALS INC | 4,900,000 | $149,058 | 2.9% | $16.29 | +85.6% | Common | 98420N105 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,535,000 | $109,875 | 2.2% | $120.44 | -39.0% | Common | 558868105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 9,220,000 | $101,789 | 2.0% | $16.40 | -20.1% | Common | 462260100 |
| KURA | KURA ONCOLOGY INC | 4,800,000 | $87,984 | 1.7% | $23.38 | -38.5% | Common | 50127T109 |
| KRYS | KRYSTAL BIOTECH INC | 1,075,000 | $70,585 | 1.4% | $60.54 | +2.7% | Common | 501147102 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 6,500,000 | $68,770 | 1.4% | $11.97 | -13.8% | Common | 09058V103 |
| — | IVERIC BIO INC | 7,120,000 | $68,494 | 1.4% | $6.39 | — | Common | 46583P102 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 900,000 | $66,843 | 1.3% | $97.48 | — | ETF | 78464A870 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 750,000 | $44,745 | 0.9% | $64.00 | -3.9% | Common | 90400D108 |
| PMVP | PMV PHARMACEUTICALS INC | 3,100,000 | $44,175 | 0.9% | $25.09 | -42.0% | Common | 69353Y103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,222,222 | $42,756 | 0.8% | $20.62 | -19.2% | Common | 87164F105 |
| — | MERSANA THERAPEUTICS INC | 7,550,000 | $34,881 | 0.7% | $21.34 | — | Common | 59045L106 |
| MNKD | MANNKIND CORP | 9,100,000 | $34,671 | 0.7% | $3.56 | +3.3% | Common | 56400P706 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,311,536 | $32,023 | 0.6% | $20.37 | -50.7% | Common | 61225M102 |
| DSGN | DESIGN THERAPEUTICS INC | 2,222,222 | $31,111 | 0.6% | $25.91 | -47.9% | Common | 25056L103 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $30,385 | 0.6% | $6.26 | — | Common | 23257D103 |
| KYMR | KYMERA THERAPEUTICS INC | 1,260,000 | $24,809 | 0.5% | $42.48 | -45.0% | Common | 501575104 |
| WHWK | AADI BIOSCIENCES INC | 1,829,402 | $22,538 | 0.4% | $30.48 | -51.3% | Common | 00032Q104 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,300,000 | $18,889 | 0.4% | $24.59 | -39.5% | Common | 05370A108 |
| — | DICE THERAPEUTICS INC | 1,075,000 | $16,684 | 0.3% | $26.26 | — | Common | 23345J104 |
| — | MARINUS PHARMACEUTICALS INC | 3,150,000 | $15,246 | 0.3% | $12.20 | — | Common | 56854Q200 |
| NUVL | NUVALENT INC | 1,049,471 | $14,231 | 0.3% | $29.01 | -63.5% | Common | 670703107 |
| IOBT | IO BIOTECH INC | 2,055,883 | $9,601 | 0.2% | $9.66 | -36.6% | Common | 449778109 |
| — | AMARIN CORP PLC | 6,000,000 | $8,940 | 0.2% | $8.22 | — | Sponsored ADR | 023111206 |
| TNGX | TANGO THERAPEUTICS INC | 1,550,000 | $7,022 | 0.1% | $11.99 | -49.5% | Common | 87583X109 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $6,780 | 0.1% | $9.85 | -41.1% | Common | 31447P100 |
| RLAY | RELAY THERAPEUTICS INC | 400,000 | $6,700 | 0.1% | $21.43 | 0.0% | Common | 75943R102 |
| — | APPLIED MOLECULAR TRANS INC | 1,030,000 | $2,997 | 0.1% | $7.52 | — | Common | 03824M109 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $86 | 0.0% | $2.62 | -89.3% | Common | 372427401 |